Home/Directory/University Core Facilities/Early Drug Discovery Unit (EDDU), The Neuro, McGill University

Early Drug Discovery Unit (EDDU), The Neuro, McGill University

Montreal, QC · Canada

University Core Facilitiessmall

Specialization: iPSC-based assays and high-content screening for brain disorders

Key Differentiator

Combines patient-derived stem cells, assay development and automated high-content screening focused on neurological disease.

Core Services

Patient-derived iPSC lines; iPSC assay development; Automated high-content screening; iPSC training and protocols

Capabilities

iPSC lines from Parkinson's and ALS patientsNeural cell differentiationHigh content screeningAssay development

Market Intelligence

The unit started as the iPSC/CRISPR Platform in 2015 and was renamed EDDU in 2019. It reports 40+ industry partnered projects and released an iPSC catalogue in 2024.

Website

www.mcgill.ca/neuro/research/eddu/about-eddu

Similar Companies

McMaster MRCMS & NMR

Hamilton, ON (1280 Main St W) · Mass spectrometry + NMR + X-ray diffraction

McMaster MS (since 1986) + NMR + XRD cores

Northwestern IMSERC

Evanston, IL · Integrated NMR, MS, X-ray crystallography

Combined MS+NMR+XRD cores

Rutgers CAFT Mass Spectrometry

New Brunswick, NJ · MS for pharma, food, chemical analysis

Rutgers advanced MS facility

UBC Pharmaceutical Sciences Analytical Suite

Vancouver, BC · NMR, UHPLC-MS/MS for pharmaceutical research

UBC Pharma school analytical suite

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.